# MarketFlow Predictive Usefulness Reassessment Using Refined Evidence v1 Plan

## Purpose

Define the controlled path from the reviewed refined-evidence results through an offline predictive-usefulness reassessment and toward a possible future acceptance-readiness review. The current implementation creates only the reassessment-review rerun package and grants no acceptance or runtime authority.

## Source Refined-Evidence Results Review

- Source artifact/status: `ADDITIONAL_PREDICTIVE_EVIDENCE_RESULTS_REVIEW_FOR_REFINED_EVIDENCE_PACKAGE` / `ADDITIONAL_PREDICTIVE_EVIDENCE_RESULTS_REVIEW_FOR_REFINED_EVIDENCE_PACKAGE_READY`.
- Source review digest: `539d06be9b20edee5ff883030e4fd1091fdaefb468fa595001178bf7ec0740da`.
- Source execution/approval digests: `9cf962933620f066dfb105845428a262743f9f36dbc2850838321f23de10b5fd` / `5ad7b3b8df3156ab6b35b9490dcd4ae05bda3d1a7786212481b78d549103a8dd`.
- The source review is research-only and opens only the reassessment-review rerun gate.

## Registry-Approved Dataset Metadata

- Dataset: `expanded_universe_canonical_dataset_v1`.
- Scope/status/label: `CANONICAL_DATASET_GENERATION_RESEARCH_ONLY` / `APPROVED_FOR_RESEARCH_REGISTRY_ONLY` / `RESEARCH_ONLY_NON_ACTIONABLE`.
- Profile/timeframe/range: `RTH_FULL_SESSION_1D` / `1d` / `2022-01-01` through `2025-12-31`.
- Exact universe: `MSFT`, `NVDA`, `AMZN`, `GOOGL`, `META`, `TSLA`, `JPM`, `XOM`, `JNJ`, `WMT`, `CAT`, `LMT`.
- Total records: `11946`; META `913`; all others `1003`.

## Refined Evidence Facts

- Labels: 7 families, 82,698 available and 924 unavailable values.
- Features: 9 groups, 11 categories, 19 fields, and 11,946 rows.
- Protocol: 6 groups with chronological splits, one-session embargo, no shuffle, and no lookahead.
- Walk-forward/OOS: 4 folds, 3,024 walk-forward rows, 2,988 OOS rows, and accuracy range `0.119813 to 0.480924`.
- Model/leakage/data quality: 5 model groups, 7 comparisons, 3 unavailable families, leakage `PASS`, and data quality `PASS_WITH_PRESERVED_SOURCE_LIMITATION`.

## Reassessment Classification

- Review status: `COMPLETED_RESEARCH_ONLY`.
- Predictive signal: `WEAK_OR_MIXED`; baseline outperformance: `INSUFFICIENT_OR_MIXED`.
- OOS: `LOW_TO_MIXED_NOT_ACCEPTANCE_EVIDENCE`.
- Model comparison and calibration/stability remain non-acceptance evidence.
- The reassessment supports a future acceptance-readiness review rerun but neither supports direct acceptance nor recommends acceptance.

## Review Domains

- Review label/feature coverage, protocol, walk-forward, OOS, model comparison, calibration/stability, leakage/quality, data quality, META limitation, and operator acceptance boundary.
- Every domain remains `RESEARCH_ONLY_NON_ACTIONABLE` and `NOT_ACCEPTANCE`.

## Future Chain

1. Predictive Usefulness Acceptance Readiness Review Rerun Using Refined Evidence.
2. Predictive Usefulness Acceptance Candidate, only if readiness passes.
3. Predictive Usefulness Acceptance Ceremony, only if separately approved.
4. Profitability review chain, if separately required.
5. Runtime migration chain, if ever separately authorized.

## Future Gates

- `predictive_usefulness_acceptance_readiness_review_rerun_using_refined_evidence`
- `predictive_usefulness_acceptance_candidate_if_ready`
- `predictive_usefulness_acceptance_ceremony_if_ready`
- `profitability_review_chain_if_required`
- `runtime_migration_chain_if_ever_authorized`

## Risk Controls

- No acceptance from reassessment and no acceptance without a separate readiness review and ceremony.
- No profitability acceptance without a separate review and no runtime source switch.
- No provider, acquisition, dataset regeneration, refined-evidence rerun, recomputation, scoring, recommendation, automatic stitching, paper trading, or broker execution.
- Preserve the frozen dataset, exact per-ticker counts, META limitation, and research-only labels.
- Low-to-mixed OOS accuracy, model comparison, and calibration/stability are not acceptance evidence by themselves.

## Non-Goals

- Predictive Usefulness Acceptance Readiness Review Rerun Using Refined Evidence.
- Predictive-usefulness acceptance candidate or acceptance ceremony.
- Profitability acceptance or runtime migration.
- Strategy activation, paper trading, broker execution, or trade recommendations.
- Provider access, acquisition, regeneration, refined-evidence execution, metric recomputation, or model-comparison rerun.

## Guardrails

- Bind only the exact reviewed source digests, registry metadata, universe order, per-ticker counts, and refined evidence facts.
- Produce deterministic package and per-ticker digests.
- Keep all planned outputs `PLANNED_NOT_GENERATED` and `RESEARCH_ONLY_NON_ACTIONABLE`.
- Fail closed on changed evidence, missing domains/gates/controls, altered per-ticker digests, or any acceptance/runtime flag.

## Current Progress

- Additional Predictive Evidence Results Review for Refined Evidence v1 is completed.
- Predictive Usefulness Reassessment Review Rerun Using Refined Evidence v1 is completed as an offline, digest-bound, research-only package.
- Predictive Usefulness Acceptance Readiness Review Rerun Using Refined Evidence v1 is implemented with decision `PREDICTIVE_USEFULNESS_ACCEPTANCE_NOT_READY_USING_REFINED_EVIDENCE`.
- Refined-evidence improvement or additional-evidence planning remains future work.
- The predictive-usefulness acceptance ceremony remains closed. Predictive usefulness and profitability remain `not accepted`; runtime activation remains future and separate.
- Predictive Evidence Planning Tree Review v1 is implemented as an offline, digest-bound review package.
- Both the original and refined-evidence readiness gates remain not ready.
- The recommended next step is a method diagnostic review before any further evidence-execution loop.

## Next Tasks

1. Method Diagnostic Review v1, if desired, or pause and archive the research chain.
2. Any redesign or evidence-scope candidate requires its own operator review before execution is considered.
3. Predictive-usefulness acceptance remains unavailable unless a future evidence cycle separately passes readiness; profitability and runtime remain separate and closed.
